- Home
- ALTS
as 05-08-2025 4:00pm EST
Stocks
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.
| Founded: | 1976 | Country: | United States |
| Employees: | N/A | City: | LAS VEGAS |
| Market Cap: | 103.4M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 146.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.29 - $7.75 | Next Earning Date: | 05-16-2025 |
| Revenue: | $12,532,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest ALT5 SIGMA CORPORATION News
ALTS Breaking Stock News: Dive into ALTS Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
Calculating The Intrinsic Value Of ALT5 Sigma Corporation (NASDAQ:ALTS)
Yahoo Finance Video
3 months ago
AST SpaceMobile stock jumps on FCC approval
ACCESSWIRE
4 months ago
Alyea Therapeutics to Present at Biotech Showcase 2025 During 43rd Annual J.P. Morgan Healthcare Conference Week
ACCESSWIRE
5 months ago
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
NewMediaWire
6 months ago
ALT5 Sigma Corporation Announces Participation at The Spartan Capital Investor Conference
Compare ALTS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALTS ALT5 SIGMA CORPORATION - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.